• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

NABsys

edit

NABsys is a life sciences company working at the intersection of physics, biology, and computer science to revolutionize medicine through clinical-grade whole-genome DNA sequencing. NABsys is one of five companies to receive a “$1000 Genome” award from the National Human Genome Research Institute of the National Institutes of Health.

Recent Milestones

edit

• 
  NABsys received $20M in Series D funding. (3/13/13)
  Posted 3/13/13 at 3:40pm via finsmes.com
• 
  NABsys received $10M in Series C funding. (9/14/11)
  Posted 9/14/11 at 6:06pm via masshightech.com
• 
  NABsys received $7M in Series B funding. (3/10/10)
  Posted 3/10/10 at 2:37am via onbiovc.com
• 
  NABsys added Barrett Bready as President and CEO, Director.
  Posted 3/10/10 at 2:37am
• 
  NABsys added David Martirano as Board.
  Posted 9/6/11 at 11:30am
• 
  NABsys added Stan Rose as Board Director and COO.
  Posted 5/2/13 at 7:41am

Videos

Screenshots

edit

Above: Home Page
Uploaded: 3/10/10

Sources

1. NABsys, Inc.: Series B $7M (onbiovc.com) [edit]
2. NABsys nabs $10M in VC financing round (masshightech.com) [edit]
3. Nabsys Closes $20M Series D Financing (finsmes.com) [edit]